Back to company

MS-OMICS ApS: Financial statements 2025

CVR: 36070374

MS-OMICS ApS (CVR 36070374) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 16,799,037 and a net result of DKK 806,990 compared with DKK 2,341,741 the year before. That is a decrease of 3.9% compared with the year before. Equity amounted to DKK 3,170,348. The solvency ratio was 17.5%. The company had 13 employees in the financial year.

Gross Profit
16,799,037 kr.
Profit/Loss
806,990 kr.
Equity
3,170,348 kr.
Total Assets
18,137,340 kr.
Employees
13

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-16.8 mio.807 t.3.2 mio.13
2024-17.5 mio.2.3 mio.2.4 mio.14
2023-15.4 mio.423 t.22 t.13
2022-10.7 mio.-155 t.-402 t.11
2021-7.3 mio.419 t.70 t.10

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like MS-OMICS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

MS-OMICS ApS: The 2024 annual report is outJun 6, 2025

MS-OMICS ApS has published its annual report for 2024. Gross profit came to DKK 17,473,765, and the net result was DKK 2,341,741.

Anders Mohr Christensen joins the board of MS-OMICS ApSFeb 19, 2025

As of February 19, 2025, Anders Mohr Christensen has joined the board of directors of MS-OMICS ApS.

About MS-OMICS ApS

MS-OMICS ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Anders Mohr Christensen. The company is owned by Clinical-Microbiomics A/S. The company has 6 employees. In 2025, the company reported a gross profit of DKK 16,799,037 and a net result of DKK 806,990 compared with DKK 2,341,741 the year before. Equity amounted to DKK 3,170,348.